These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 17625780)
61. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen. Cameron DW; Becker S; King MS; da Silva B; Klein C; Tokimoto D; Foit C; Calhoun D; Bernstein B; Hanna GJ J Antimicrob Chemother; 2007 May; 59(5):957-63. PubMed ID: 17350990 [TBL] [Abstract][Full Text] [Related]
66. Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients. Pace CS; Martin AM; Hammond EL; Mamotte CD; Nolan DA; Mallal SA Antivir Ther; 2003 Aug; 8(4):323-31. PubMed ID: 14518702 [TBL] [Abstract][Full Text] [Related]
67. Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimen. Yilmaz A; Ståhle L; Hagberg L; Svennerholm B; Fuchs D; Gisslén M Scand J Infect Dis; 2004; 36(11-12):823-8. PubMed ID: 15764168 [TBL] [Abstract][Full Text] [Related]
68. CYP3A5 genotype has no impact on plasma trough concentrations of lopinavir and ritonavir in HIV-infected subjects. Estrela RC; Santoro AB; Barroso PF; Tuyama M; Suarez-Kurtz G Clin Pharmacol Ther; 2008 Aug; 84(2):205-7. PubMed ID: 18288082 [TBL] [Abstract][Full Text] [Related]
70. Inflammatory oedema of the legs: a new side-effect of lopinavir. Lascaux AS; Lesprit P; Bertocchi M; Levy Y AIDS; 2001 Apr; 15(6):819. PubMed ID: 11371707 [No Abstract] [Full Text] [Related]
71. Outcomes of switch to atazanavir-containing combination antiretroviral therapy in HIV-1-infected patients with hyperlipidemia. Lu CL; Lin YH; Wong WW; Lin HH; Ho MW; Wang NC; Hsieh SM; Sheng WH; Hung CC; Chen MY J Microbiol Immunol Infect; 2011 Aug; 44(4):258-64. PubMed ID: 21524961 [TBL] [Abstract][Full Text] [Related]
72. [Darunavir in treatment-naïve patients. The ARTEMIS study]. Estrada V; Fuster M Enferm Infecc Microbiol Clin; 2008 Oct; 26 Suppl 10():10-3. PubMed ID: 19195454 [TBL] [Abstract][Full Text] [Related]
74. Ritonavir-boosted antiretroviral therapy with paclitaxel: will it lead to boosted toxicity? Murdoch IG; Jacobs TG; Nieuwenhuize RM; van Rossum-Schornagel QC; Schurink CAM; van Erp NP; Burger DM AIDS; 2022 Feb; 36(2):322-323. PubMed ID: 34934024 [No Abstract] [Full Text] [Related]
75. Antiretroviral therapy and the human immunodeficiency virus--improved survival but at what cost? Bradbury RA; Samaras K Diabetes Obes Metab; 2008 Jun; 10(6):441-50. PubMed ID: 17825081 [TBL] [Abstract][Full Text] [Related]